|
G
|
Agt
|
angiotensinogen
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [AGT protein promotes the reaction [SREBF1 protein binds to TGFB1 promoter]]; salubrinal inhibits the reaction [AGT protein results in increased cleavage of SREBF1 protein]; salubrinal inhibits the reaction [AGT protein results in increased expression of FN1 protein]; salubrinal inhibits the reaction [AGT protein results in increased expression of SREBF1 mRNA]; salubrinal inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; salubrinal inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein]; salubrinal inhibits the reaction [AGT protein results in increased secretion of TGFB1 protein]
|
CTD |
PMID:25398788 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein]
|
CTD |
PMID:25398788 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
G
|
Atf3
|
activating transcription factor 3
|
increases expression
|
ISO
|
salubrinal results in increased expression of ATF3 mRNA
|
CTD |
PMID:23690448 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
G
|
Atf4
|
activating transcription factor 4
|
multiple interactions increases expression
|
ISO EXP
|
[salubrinal co-treated with EPO protein] results in decreased expression of ATF4 protein; salubrinal inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ATF4 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF4 protein]]; salubrinal promotes the reaction [T-2 Toxin results in increased expression of ATF4 protein] salubrinal results in increased expression of ATF4 protein salubrinal inhibits the reaction [decamethrin results in increased expression of ATF4 protein]; salubrinal promotes the reaction [Cisplatin results in increased expression of ATF4 protein] salubrinal inhibits the reaction [Acrylamide results in increased expression of ATF4 protein]; salubrinal promotes the reaction [Thapsigargin results in increased expression of ATF4 protein]; salubrinal promotes the reaction [Tunicamycin results in increased expression of ATF4 protein]
|
CTD |
PMID:21616140 PMID:21809093 PMID:23690448 PMID:25950987 PMID:28844859 PMID:31022492 PMID:34673134 PMID:35741090 PMID:38604440 More...
|
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
G
|
Atf6
|
activating transcription factor 6
|
increases expression
|
ISO
|
salubrinal results in increased expression of ATF6 mRNA
|
CTD |
PMID:23958496 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
ISO EXP
|
Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased expression of BAX protein]]; salubrinal promotes the reaction [Cisplatin results in increased expression of BAX protein] salubrinal inhibits the reaction [Acrylamide results in increased expression of BAX protein]; salubrinal inhibits the reaction [cadmium acetate results in increased expression of BAX protein]
|
CTD |
PMID:21616140 PMID:30605698 PMID:38604440 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions
|
ISO EXP
|
salubrinal inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein] Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]]; salubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein] salubrinal inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein]
|
CTD |
PMID:20686688 PMID:21616140 PMID:30605698 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Becn1
|
beclin 1
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cadmium Chloride results in increased expression of BECN1 protein]; salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased expression of BECN1 protein]; salubrinal promotes the reaction [MAP3K5 protein results in increased expression of BECN1 protein]
|
CTD |
PMID:20929985 PMID:33127495 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
G
|
Bnip3
|
BCL2 interacting protein 3
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cadmium Chloride results in increased expression of BNIP3 protein]
|
CTD |
PMID:33127495 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
G
|
Calr
|
calreticulin
|
multiple interactions
|
ISO
|
[salubrinal results in decreased activity of [PPP1CC protein binds to PPP1R15A protein]] which affects the localization of CALR protein
|
CTD |
PMID:17187072 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
G
|
Casp12
|
caspase 12
|
multiple interactions
|
ISO EXP
|
Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP12 protein]]; salubrinal inhibits the reaction [decamethrin results in increased expression of CASP12 protein]; salubrinal inhibits the reaction [Rotenone results in increased expression of CASP12 mRNA]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of CASP12 mRNA]; salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP12 protein] salubrinal inhibits the reaction [arsenite results in increased activity of CASP12 protein]; salubrinal inhibits the reaction [Rotenone results in increased cleavage of CASP12 protein] salubrinal inhibits the reaction [T-2 Toxin results in increased expression of CASP12 mRNA]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of CASP12 protein]
|
CTD |
PMID:18226606 PMID:21616140 PMID:25428620 PMID:26446018 PMID:31841155 PMID:34673134 More...
|
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO EXP
|
salubrinal inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]; salubrinal inhibits the reaction [MAP3K5 protein results in increased activity of CASP3 protein]; salubrinal inhibits the reaction [Paraquat results in increased activity of CASP3 protein] salubrinal inhibits the reaction [decamethrin results in increased activity of CASP3 protein]; salubrinal inhibits the reaction [decamethrin results in increased cleavage of and results in increased activity of CASP3 protein]; salubrinal inhibits the reaction [Rotenone results in increased expression of CASP3 mRNA]; salubrinal promotes the reaction [Cisplatin results in increased activity of CASP3 protein]; salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein] salubrinal inhibits the reaction [Rotenone results in increased expression of CASP3 mRNA]; salubrinal inhibits the reaction [Tetrachlorodibenzodioxin results in increased cleavage of CASP3 protein]
|
CTD |
PMID:19735704 PMID:20929985 PMID:21616140 PMID:21809093 PMID:24932542 PMID:25428620 PMID:26446018 PMID:28986289 PMID:30247739 PMID:31841155 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]]; salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]
|
CTD |
PMID:21616140 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]
|
CTD |
PMID:23958496 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
G
|
Ccl5
|
C-C motif chemokine ligand 5
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]
|
CTD |
PMID:23958496 |
|
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
|
|
G
|
Cdh1
|
cadherin 1
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cyclosporine results in decreased expression of CDH1 protein]
|
CTD |
PMID:22155090 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [Etoposide results in increased expression of CDKN1A mRNA]
|
CTD |
PMID:23690541 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [Etoposide results in increased expression of CDKN2A mRNA]
|
CTD |
PMID:23690541 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
G
|
Cybb
|
cytochrome b-245 beta chain
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [decamethrin results in increased expression of CYBB mRNA]; salubrinal inhibits the reaction [decamethrin results in increased expression of CYBB protein]
|
CTD |
PMID:35741090 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [MAP3K5 protein affects the localization of CYCS protein]; salubrinal inhibits the reaction [Paraquat affects the localization of CYCS protein]
|
CTD |
PMID:20929985 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
EIF2S1 protein promotes the reaction [salubrinal inhibits the reaction [Paraquat results in increased expression of DDIT3 protein]]; salubrinal inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [Paraquat results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of DDIT3 mRNA]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of DDIT3 protein] Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased expression of DDIT3 protein]]; salubrinal inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [decamethrin results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [Rotenone results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of DDIT3 mRNA]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [Thapsigargin results in increased expression of DDIT3 protein]; salubrinal promotes the reaction [Cisplatin results in increased expression of DDIT3 protein]; salubrinal promotes the reaction [Cyclosporine results in increased expression of DDIT3 protein]; salubrinal promotes the reaction [Tacrolimus results in increased expression of DDIT3 protein] salubrinal results in increased expression of DDIT3 mRNA salubrinal results in decreased expression of DDIT3 protein salubrinal inhibits the reaction [Acrylamide results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [cadmium acetate results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [Rotenone results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of DDIT3 protein]; salubrinal promotes the reaction [Thapsigargin results in increased expression of DDIT3 protein]; salubrinal promotes the reaction [Tunicamycin results in increased expression of DDIT3 protein]
|
CTD |
PMID:18305250 PMID:19735704 PMID:20686688 PMID:21616140 PMID:21809093 PMID:23690448 PMID:23958496 PMID:24932542 PMID:25428620 PMID:25950987 PMID:26446018 PMID:28844859 PMID:28986289 PMID:29380555 PMID:30508555 PMID:30605698 PMID:34673134 PMID:35741090 PMID:38604440 More...
|
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
G
|
Edem1
|
ER degradation enhancing alpha-mannosidase like protein 1
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Paraquat results in increased expression of EDEM1 protein]
|
CTD |
PMID:19735704 |
|
NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:143,353,624...143,388,060
|
|
G
|
Eif2a
|
eukaryotic translation initiation factor 2A
|
multiple interactions increases phosphorylation affects phosphorylation increases expression
|
ISO EXP
|
salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein]; salubrinal inhibits the reaction [EIF2A protein results in decreased susceptibility to nonivamide] salubrinal results in increased phosphorylation of EIF2A protein Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased phosphorylation of EIF2A protein]]; salubrinal promotes the reaction [Cisplatin results in increased phosphorylation of EIF2A protein] salubrinal affects the phosphorylation of EIF2A protein salubrinal results in increased expression of EIF2A protein modified form
|
CTD |
PMID:17332266 PMID:17418795 PMID:18305250 PMID:18684481 PMID:20071420 PMID:20686688 PMID:20929985 PMID:21616140 PMID:23690541 PMID:23892647 PMID:27613715 More...
|
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
|
|
G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
increases expression multiple interactions increases phosphorylation
|
ISO EXP
|
salubrinal results in increased expression of EIF2S1 protein modified form [salubrinal co-treated with EPO protein] results in increased phosphorylation of EIF2S1 protein; [salubrinal results in decreased activity of EIF2S1 protein] which results in decreased susceptibility to decamethrin; EIF2S1 protein promotes the reaction [salubrinal inhibits the reaction [Paraquat results in increased expression of DDIT3 protein]]; EIF2S1 protein promotes the reaction [salubrinal inhibits the reaction [Paraquat results in increased expression of HSPA5 protein]]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2S1 protein]]; salubrinal promotes the reaction [Cadmium Chloride results in increased phosphorylation of EIF2S1 protein]; salubrinal promotes the reaction [Paraquat results in increased expression of EIF2S1 protein modified form]; salubrinal results in increased phosphorylation of and results in decreased activity of EIF2S1 protein salubrinal results in increased phosphorylation of EIF2S1 protein [salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK1 protein; [salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK3 protein; [salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK8 protein; [salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK9 protein; salubrinal inhibits the reaction [cadmium acetate results in increased expression of EIF2S1 protein modified form]; salubrinal inhibits the reaction [Rotenone results in decreased phosphorylation of EIF2S1 protein]; salubrinal inhibits the reaction [Thapsigargin results in increased expression of EIF2S1 mRNA]; salubrinal inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 mRNA]; salubrinal promotes the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of EIF2S1 protein] salubrinal inhibits the reaction [Rotenone results in decreased phosphorylation of EIF2S1 protein]; salubrinal promotes the reaction [T-2 Toxin results in increased phosphorylation of EIF2S1 protein]
|
CTD |
PMID:21147958 PMID:21555338 PMID:21809093 PMID:23690448 PMID:24932542 PMID:25170120 PMID:25428620 PMID:25950987 PMID:26446018 PMID:28844859 PMID:28986289 PMID:29380555 PMID:30605698 PMID:31022492 PMID:34673134 More...
|
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
G
|
Epo
|
erythropoietin
|
multiple interactions
|
ISO
|
[salubrinal co-treated with EPO protein] results in decreased expression of ATF4 protein; [salubrinal co-treated with EPO protein] results in increased phosphorylation of EIF2S1 protein
|
CTD |
PMID:23690448 |
|
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
G
|
Fn1
|
fibronectin 1
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [AGT protein results in increased expression of FN1 protein]
|
CTD |
PMID:25398788 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
G
|
Foxo3
|
forkhead box O3
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cadmium Chloride results in increased expression of FOXO3 protein]
|
CTD |
PMID:33127495 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [Rotenone results in decreased activity of GSR protein]
|
CTD |
PMID:26446018 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions
|
ISO
|
salubrinal promotes the reaction [Cisplatin results in increased expression of HAVCR1 mRNA]
|
CTD |
PMID:21616140 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
G
|
Hgf
|
hepatocyte growth factor
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [Thapsigargin results in decreased expression of HGF mRNA]; salubrinal inhibits the reaction [Thapsigargin results in decreased expression of HGF protein]; salubrinal inhibits the reaction [Tunicamycin results in decreased expression of HGF mRNA]; salubrinal inhibits the reaction [Tunicamycin results in decreased expression of HGF protein]
|
CTD |
PMID:28844859 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Isoniazid results in increased expression of HMOX1 mRNA]
|
CTD |
PMID:40015660 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions increases expression
|
ISO EXP
|
EIF2S1 protein promotes the reaction [salubrinal inhibits the reaction [Paraquat results in increased expression of HSPA5 protein]]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; salubrinal inhibits the reaction [Paraquat results in increased expression of HSPA5 protein]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 mRNA]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 protein] salubrinal inhibits the reaction [Rotenone results in increased expression of HSPA5 protein]; salubrinal inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; salubrinal promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of HSPA5 protein] salubrinal results in increased expression of HSPA5 protein salubrinal inhibits the reaction [Rotenone results in increased expression of HSPA5 protein]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 mRNA]; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 protein]
|
CTD |
PMID:19735704 PMID:24932542 PMID:25428620 PMID:26446018 PMID:28844859 PMID:28986289 PMID:31022492 PMID:34673134 More...
|
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [decamethrin results in increased expression of IL1B mRNA]; salubrinal inhibits the reaction [decamethrin results in increased expression of IL1B protein]
|
CTD |
PMID:35741090 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [decamethrin results in increased expression of IL6 mRNA]; salubrinal inhibits the reaction [decamethrin results in increased expression of IL6 protein]
|
CTD |
PMID:35741090 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
affects response to substance multiple interactions
|
ISO
|
salubrinal affects the susceptibility to MAP3K5 protein salubrinal affects the susceptibility to [Paraquat co-treated with MAP3K5 protein]; salubrinal inhibits the reaction [MAP3K5 protein affects the localization of CYCS protein]; salubrinal inhibits the reaction [MAP3K5 protein results in increased activity of CASP3 protein]; salubrinal inhibits the reaction [Paraquat results in increased phosphorylation of and results in increased activity of MAP3K5 protein]; salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein]; salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased expression of BECN1 protein]; salubrinal promotes the reaction [MAP3K5 protein results in increased degradation of SQSTM1 protein]; salubrinal promotes the reaction [MAP3K5 protein results in increased expression of BECN1 protein]
|
CTD |
PMID:19735704 PMID:20929985 |
|
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO EXP
|
salubrinal inhibits the reaction [Cyclosporine results in increased phosphorylation of MAPK1 protein] [salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:21147958 PMID:22155090 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk14
|
mitogen activated protein kinase 14
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK14 protein]
|
CTD |
PMID:21809093 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO EXP
|
salubrinal inhibits the reaction [Cyclosporine results in increased phosphorylation of MAPK3 protein] [salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK3 protein
|
CTD |
PMID:21147958 PMID:22155090 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
EXP ISO
|
[salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK8 protein salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK8 protein]; salubrinal inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:20686688 PMID:21147958 PMID:21809093 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions
|
ISO EXP
|
salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein] [salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK9 protein
|
CTD |
PMID:20686688 PMID:21147958 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
G
|
Mmp13
|
matrix metallopeptidase 13
|
multiple interactions
|
ISO
|
[salubrinal co-treated with T-2 Toxin] results in increased expression of MMP13 mRNA; salubrinal inhibits the reaction [T-2 Toxin results in increased expression of MMP13 protein]
|
CTD |
PMID:34673134 |
|
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
G
|
Myh3
|
myosin heavy chain 3
|
decreases expression
|
ISO
|
salubrinal results in decreased expression of MYH3 protein
|
CTD |
PMID:29380555 |
|
NCBI chr10:52,269,185...52,293,000
Ensembl chr10:52,269,185...52,293,000
|
|
G
|
Myod1
|
myogenic differentiation 1
|
decreases expression
|
ISO
|
salubrinal results in decreased expression of MYOD1 protein
|
CTD |
PMID:29380555 |
|
NCBI chr 1:106,021,161...106,023,871
Ensembl chr 1:106,021,161...106,023,871
|
|
G
|
Myog
|
myogenin
|
decreases expression
|
ISO
|
salubrinal results in decreased expression of MYOG protein
|
CTD |
PMID:29380555 |
|
NCBI chr13:48,297,476...48,300,065
Ensembl chr13:48,297,235...48,300,065
|
|
G
|
Ngf
|
nerve growth factor
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [decamethrin results in decreased expression of NGF protein]
|
CTD |
PMID:31841155 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [decamethrin results in increased expression of NOS2 protein]
|
CTD |
PMID:35741090 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Nox4
|
NADPH oxidase 4
|
multiple interactions increases expression
|
ISO
|
Acetylcysteine inhibits the reaction [salubrinal results in increased expression of [Cisplatin results in increased expression of NOX4 protein]]
|
CTD |
PMID:21616140 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]; salubrinal inhibits the reaction [Cyclosporine results in increased cleavage of PARP1 protein]
|
CTD |
PMID:21809093 PMID:22155090 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
G
|
Ppp1cc
|
protein phosphatase 1 catalytic subunit gamma
|
multiple interactions
|
ISO
|
[salubrinal results in decreased activity of [PPP1CC protein binds to PPP1R15A protein]] which affects the localization of CALR protein
|
CTD |
PMID:17187072 |
|
NCBI chr12:40,043,822...40,061,301
Ensembl chr12:40,043,822...40,061,341
|
|
G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
multiple interactions increases expression
|
ISO
|
[salubrinal results in decreased activity of [PPP1CC protein binds to PPP1R15A protein]] which affects the localization of CALR protein salubrinal results in increased expression of PPP1R15A protein
|
CTD |
PMID:17187072 PMID:23690448 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
G
|
Slc38a2
|
solute carrier family 38, member 2
|
multiple interactions
|
ISO
|
salubrinal promotes the reaction [arsenic trioxide results in increased expression of SLC38A2 mRNA]
|
CTD |
PMID:23892647 |
|
NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:129,730,450...129,742,619
|
|
G
|
Smad2
|
SMAD family member 2
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cyclosporine results in increased phosphorylation of and results in increased activity of SMAD2 protein]
|
CTD |
PMID:22155090 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
G
|
Sqstm1
|
sequestosome 1
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cadmium Chloride results in decreased expression of SQSTM1 protein]; salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein]; salubrinal promotes the reaction [MAP3K5 protein results in increased degradation of SQSTM1 protein]
|
CTD |
PMID:20929985 PMID:33127495 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [AGT protein promotes the reaction [SREBF1 protein binds to TGFB1 promoter]]; salubrinal inhibits the reaction [AGT protein results in increased cleavage of SREBF1 protein]; salubrinal inhibits the reaction [AGT protein results in increased expression of SREBF1 mRNA]
|
CTD |
PMID:25398788 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [AGT protein promotes the reaction [SREBF1 protein binds to TGFB1 promoter]]; salubrinal inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; salubrinal inhibits the reaction [AGT protein results in increased secretion of TGFB1 protein]
|
CTD |
PMID:25398788 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Th
|
tyrosine hydroxylase
|
multiple interactions
|
EXP
|
salubrinal inhibits the reaction [Rotenone results in decreased expression of TH protein]
|
CTD |
PMID:26446018 |
|
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
G
|
Tjp1
|
tight junction protein 1
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [Cyclosporine results in decreased expression of TJP1 protein]
|
CTD |
PMID:22155090 |
|
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
salubrinal inhibits the reaction [decamethrin results in increased expression of TNF mRNA]; salubrinal inhibits the reaction [decamethrin results in increased expression of TNF protein]
|
CTD |
PMID:35741090 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Trib3
|
tribbles pseudokinase 3
|
multiple interactions
|
ISO
|
salubrinal promotes the reaction [arsenic trioxide results in increased expression of TRIB3 mRNA]
|
CTD |
PMID:23892647 |
|
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
increases expression multiple interactions
|
EXP
|
salubrinal results in increased expression of VEGFA mRNA salubrinal promotes the reaction [Thapsigargin results in increased expression of VEGFA mRNA]
|
CTD |
PMID:28844859 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|